| Part Of Safety of Arthritis Drugs, Day 1,
Report Video IssueSafety of Arthritis Drugs, Day 1, Part 2
2005-02-23T11:07:31-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJkZWZhdWx0c1wvQ2FwaXRvbF9kZWZhdWx0LWltYWdlLmpwZyIsImVkaXRzIjp7InJlc2l6ZSI6eyJmaXQiOiJjb3ZlciIsImhlaWdodCI6NTA2fX19A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Physicians and others spoke at the meeting to assess the safety records of arthritis drugs. Among the topics they addressed were the mechanisms for the deployment of the medicine, risk factors calculated in initial tests, and the degree of usage of the class of drugs among the general population. They also answered questions from Food and Drug Administration officials.
Physicians and others spoke at the meeting to assess the safety records of arthritis drugs. Among the topics they addressed were the mechanisms for the deployment of the medicine, risk factors calculated in initial tests, and the degree of usage of the class of drugs among the general population. They also answered questions from Food and Drug Administration officials.
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of… read more
A joint meeting of the Food and Drug Administration’s Arthritis and Drug Safety and Risk Management Advisory Committees held a forum on the safety of “COX-2” inhibitors. The function of the advisory committee was to provide advice and recommendations to the FDA on regulatory issues.
Physicians and others spoke at the meeting to assess the safety records of arthritis drugs. Among the topics they addressed were the mechanisms for the deployment of the medicine, risk factors calculated in initial tests, and the degree of usage of the class of drugs among the general population. They also answered questions from Food and Drug Administration officials. close
People in this video
Hosting Organization
More Videos From
Safety of Arthritis Drugs, Day 1,
More Videos
Purchase a Download
Safety of Arthritis Drugs, Day 1, Part 2
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Presidential Radio Address
In his weekly radio address President Bush talked about the May 15 deadline for signing up for the new Medicare…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional…
-
FDA Oversight of Food Safety
Representative Timothy Murphy talked about today’s House Energy and Commerce hearing on the Salmonella outbreak, and he…
-
National Public Safety Communications Network
Police chiefs, sheriffs, and fire chiefs spoke to reporters and answered questions about the need for an interoperable…